Intersource 125, Model 1251L
Source, Brachytherapy, Radionuclide. 510(k) K984235, from International Brachytherapy, Inc. (Norcross, GA). Product code KXK, class 2.
As of Nov 20, 2026, K984235 is an FDA 510(k) held by International Brachytherapy, Inc., substantially equivalent on Jun 9, 1999 after 196 days, with no recalls tied to it in FDA's recall database.
- Review time: 196 days
- Recalls: 0
InterSource 125 implants are indicated for interstitial implantation of select localized tumors with low to moderate radiosensitivity. They are used either as primary treatment for tumors such as those of the head, lung, neck, pancreas, prostate, and unresectable tumors, or for residual disease after excision of the primary tumor.
- I-125 Seeds, Code: 6711K914281 · Medi-Physics Inc. Dba Nycomed Amersham Imaging · Nov 22, 1991
- OncoPatchK252296 · Oncopatch, Inc. · Dec 5, 2025
- IsoSphereK242818 · Isoaid, LLC · Jul 15, 2025
- RadianceTx Radionuclide Brachytherapy SourceK223465 · Radiance Therapeutics, Inc. · Jan 11, 2023
- GammaTileK221539 · Gt Medical Technologies · Nov 9, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Nov 25, 1998
- Review panel
- Radiology
- Regulation
- 21 CFR 892.5730
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files